Published in Lancet on May 10, 1997
Host alloreactive memory T cells influence tolerance to kidney allografts in nonhuman primates. Sci Transl Med (2011) 1.97
Transplantation tolerance through mixed chimerism. Nat Rev Nephrol (2010) 1.17
Dissociation between peripheral blood chimerism and tolerance to hindlimb composite tissue transplants: preferential localization of chimerism in donor bone. Transplantation (2009) 0.87
Microchimerism in promoting graft acceptance in clinical transplantation. Curr Opin Organ Transplant (2011) 0.81
Naturally acquired microchimerism: implications for transplantation outcome and novel methodologies for detection. Chimerism (2014) 0.80
Tolerance induction strategies in vascularized composite allotransplantation: mixed chimerism and novel developments. Clin Dev Immunol (2012) 0.77
Tolerance in renal transplantation: is mixed chimerism the missing link? Nephrol Dial Transplant (2009) 0.76
Microchimerism and graft tolerance: cause or effect? Lancet (1997) 0.75
Evaluation of the tolerogenic effects of donor bone marrow cells using a severe combined immunodeficient mouse-human islet transplant model. Hum Immunol (2008) 0.75
HLA-targeted cell sorting of microchimeric cells opens the way to phenotypical and functional characterization. Chimerism (2012) 0.75
Chimerism in women with end stage renal diseases: Who's who? Chimerism (2012) 0.75
On the crossroad between tolerance and posttransplant lymphoma. Curr Opin Organ Transplant (1997) 0.75
Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature (1996) 6.61
A phase III study of belatacept-based immunosuppression regimens versus cyclosporine in renal transplant recipients (BENEFIT study). Am J Transplant (2010) 5.40
4-1BB costimulatory signals preferentially induce CD8+ T cell proliferation and lead to the amplification in vivo of cytotoxic T cell responses. J Exp Med (1997) 3.31
Structure of human factor VIII. Nature (1984) 3.29
Dendritic cell loss from nonlymphoid tissues after systemic administration of lipopolysaccharide, tumor necrosis factor, and interleukin 1. J Exp Med (1995) 3.16
The effect of race on access and outcome in transplantation. N Engl J Med (1991) 2.98
Functional expression of the costimulatory molecule, B7/BB1, on murine dendritic cell populations. J Exp Med (1992) 2.79
Selective targeting of human alloresponsive CD8+ effector memory T cells based on CD2 expression. Am J Transplant (2010) 2.37
Transplantation tolerance induced by CTLA4-Ig. Transplantation (1994) 2.36
Asialo GM1(+) CD8(+) T cells play a critical role in costimulation blockade-resistant allograft rejection. J Clin Invest (1999) 2.26
Viscosity and retinal vein thrombosis. Br J Ophthalmol (1976) 2.12
Regulation of immunostimulatory function and costimulatory molecule (B7-1 and B7-2) expression on murine dendritic cells. J Immunol (1994) 2.09
Guidelines for the diagnosis, investigation and management of polycythaemia/erythrocytosis. Br J Haematol (2005) 1.96
Role of CD28-B7 interactions in generation and maintenance of CD8 T cell memory. J Immunol (2001) 1.96
Three-year outcomes from BENEFIT, a randomized, active-controlled, parallel-group study in adult kidney transplant recipients. Am J Transplant (2011) 1.93
IFN-gamma is critical for long-term allograft survival induced by blocking the CD28 and CD40 ligand T cell costimulation pathways. J Immunol (1998) 1.86
Effect of haematocrit on cerebral blood-flow in man. Lancet (1977) 1.80
Cerebral blood-flow in polycythaemia. Lancet (1977) 1.79
Renal transplantation using belatacept without maintenance steroids or calcineurin inhibitors. Am J Transplant (2014) 1.70
A mouse model for polyomavirus-associated nephropathy of kidney transplants. Am J Transplant (2006) 1.65
4-1BB ligand, a member of the TNF family, is important for the generation of antiviral CD8 T cell responses. J Immunol (1999) 1.63
CD40-gp39 interactions play a critical role during allograft rejection. Suppression of allograft rejection by blockade of the CD40-gp39 pathway. Transplantation (1996) 1.63
Cytokine gene transcription in vascularised organ grafts: analysis using semiquantitative polymerase chain reaction. J Exp Med (1991) 1.62
Donor-recipient microchimerism is not required for tolerance induction following recipient pretreatment with donor-specific transfusion and anti-CD4 antibody. Evidence of a clear role for short-term antigen persistence. Transplantation (1995) 1.58
Organ donation and utilization, 1995-2004: entering the collaborative era. Am J Transplant (2006) 1.57
Evidence for kidney rejection after combined bone marrow and renal transplantation despite ongoing whole-blood chimerism in rhesus macaques. Am J Transplant (2012) 1.54
The violent collisional history of asteroid 4 Vesta. Science (2012) 1.52
Payment for immunosuppression after organ transplantation. American Society of Transplantation. JAMA (2000) 1.52
Vascular occlusive episodes and venous haematocrit in primary proliferative polycythaemia. Lancet (1978) 1.52
Cumulative exposure to gamma interferon-dependent chemokines CXCL9 and CXCL10 correlates with worse outcome after lung transplant. Am J Transplant (2011) 1.51
Identification of patients with increased risk of infection with herpes simplex virus after renal transplantation. J Infect Dis (1979) 1.50
Superiority of rapamycin over tacrolimus in preserving nonhuman primate Treg half-life and phenotype after adoptive transfer. Am J Transplant (2014) 1.50
Characterization of virus-mediated inhibition of mixed chimerism and allospecific tolerance. J Immunol (2001) 1.49
Experience with a novel efalizumab-based immunosuppressive regimen to facilitate single donor islet cell transplantation. Am J Transplant (2010) 1.48
Costimulation blockade, busulfan, and bone marrow promote titratable macrochimerism, induce transplantation tolerance, and correct genetic hemoglobinopathies with minimal myelosuppression. J Immunol (2001) 1.46
Oxygen desaturation in apparent and relative polycythaemia. BMJ (1991) 1.45
Crystal structure of the extracellular region of human tissue factor. Nature (1994) 1.43
Cutting edge: administration of anti-CD40 ligand and donor bone marrow leads to hemopoietic chimerism and donor-specific tolerance without cytoreductive conditioning. J Immunol (2000) 1.43
The classification and diagnostic criteria of the erythrocytoses (polycythaemias) Clin Lab Haematol (1999) 1.41
Postpartum thrombosis in primary thrombocythaemia. Eur J Haematol (1997) 1.40
Isolation and characterization of dendritic cells from mouse heart and kidney. J Immunol (1994) 1.40
FasL is important in costimulation blockade-resistant skin graft rejection. Transplantation (2001) 1.39
Intravenous immunoglobulin therapy in thrombocytopenic infectious mononucleosis. Clin Lab Haematol (1989) 1.39
Race and sex differences in the identification of candidates for renal transplantation. Am J Kidney Dis (1992) 1.39
Remission of essential hypertension after renal transplantation. N Engl J Med (1983) 1.38
Granulocytopenia due to fusidic acid. Lancet (1988) 1.38
Results of the double-blind, randomized, multicenter, phase III clinical trial of Thymoglobulin versus Atgam in the treatment of acute graft rejection episodes after renal transplantation. Transplantation (1998) 1.36
Induction of chimerism in rhesus macaques through stem cell transplant and costimulation blockade-based immunosuppression. Am J Transplant (2007) 1.30
Treatment of secondary hyperparathyroidism in patients with chronic renal failure by total parathyroidectomy and parathyroid autograft. Ann Surg (1981) 1.30
CD40-CD40 ligand costimulation is required for generating antiviral CD4 T cell responses but is dispensable for CD8 T cell responses. J Immunol (1999) 1.28
Transplant tolerance in non-human primates: progress, current challenges and unmet needs. Am J Transplant (2006) 1.27
An open-label, concentration-ranging trial of FK506 in primary kidney transplantation: a report of the United States Multicenter FK506 Kidney Transplant Group. Transplantation (1996) 1.27
Genetic characterization of strain differences in the ability to mediate CD40/CD28-independent rejection of skin allografts. J Immunol (2000) 1.23
Vesta's shape and morphology. Science (2012) 1.23
Sirolimus enhances the magnitude and quality of viral-specific CD8+ T-cell responses to vaccinia virus vaccination in rhesus macaques. Am J Transplant (2011) 1.23
Long-term belatacept exposure maintains efficacy and safety at 5 years: results from the long-term extension of the BENEFIT study. Am J Transplant (2013) 1.23
Prevention of primary cytomegalovirus disease in organ transplant recipients with oral ganciclovir or oral acyclovir prophylaxis. Transpl Infect Dis (2000) 1.22
Cytokine gene expression: analysis using northern blotting, polymerase chain reaction and in situ hybridization. Immunol Rev (1991) 1.21
4-1BB costimulation is required for protective anti-viral immunity after peptide vaccination. J Immunol (2000) 1.21
Pitted terrain on Vesta and implications for the presence of volatiles. Science (2012) 1.20
CD40-specific costimulation blockade enhances neonatal porcine islet survival in nonhuman primates. Am J Transplant (2011) 1.19
A retrospective study of apparent and relative polycythaemia: associated factors and early outcome. Clin Lab Haematol (1990) 1.19
Intermittent hypoxia in patients with unexplained polycythaemia. Br Med J (Clin Res Ed) (1986) 1.19
CD40 blockade combines with CTLA4Ig and sirolimus to produce mixed chimerism in an MHC-defined rhesus macaque transplant model. Am J Transplant (2011) 1.18
Inhibition of angiotensin-converting enzyme in renal-transplant recipients with hypertension. N Engl J Med (1983) 1.18
Engraftment of adult porcine islet xenografts in diabetic nonhuman primates through targeting of costimulation pathways. Am J Transplant (2007) 1.17
Miles to go…. Am J Transplant (2011) 1.17
Blocking the CD28-B7 T cell costimulation pathway induces long term cardiac allograft acceptance in the absence of IL-4. J Immunol (1997) 1.16
Purification of human factor VIII:C and its characterization by Western blotting using monoclonal antibodies. Biochemistry (1985) 1.16
Dynamic helical computed tomography scan accurately detects hemorrhage in patients with pelvic fracture. Surgery (2000) 1.16
Hyperhemolytic transfusion reaction in sickle cell disease. Transfusion (2001) 1.15
Effect of primary and recurrent cytomegalovirus infections upon graft and patient survival after renal transplantation. Transplantation (1979) 1.15
Integrin antagonists prevent costimulatory blockade-resistant transplant rejection by CD8(+) memory T cells. Am J Transplant (2011) 1.15
Belatacept and sirolimus prolong nonhuman primate renal allograft survival without a requirement for memory T cell depletion. Am J Transplant (2013) 1.14
Migration patterns of dendritic leukocytes. Implications for transplantation. Transplantation (1990) 1.13
Purification of recombinant human tissue factor. Biochemistry (1989) 1.13
A homozygous KCNJ10 mutation in Jack Russell Terriers and related breeds with spinocerebellar ataxia with myokymia, seizures, or both. J Vet Intern Med (2014) 1.12
Cloning and expression of human tissue factor cDNA. Thromb Res (1987) 1.11
High-level production of human blood coagulation factors VII and XI using a new mammalian expression vector. Gene (1994) 1.09